Erin Catherine Carter is Director of GlucoTrack, Inc.. Currently has a direct ownership of 45,632 shares of GCTK, which is worth approximately $287,937. The most recent transaction as insider was on Mar 26, 2025, when has been sold 1,896 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.6K
0% 3M change
3252.83% 12M change
Total Value Held $287,937

Erin Catherine Carter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2025
BUY
Grant, award, or other acquisition
-
1,896 Added 3.99%
45,632 Common Stock, par valu...
Mar 12 2025
BUY
Exercise of in-the-money or at-the-money derivatives securities
-
40,297 Added 47.95%
43,736 Common Stock, par valu...
Nov 14 2024
BUY
Conversion of derivative security
$64,833 $31.2 p/Share
2,078 Added 37.67%
3,439 Common Stock, par valu...
Apr 08 2024
BUY
Grant, award, or other acquisition
-
458 Added 25.18%
1,361 Common Stock, par valu...
Dec 31 2023
BUY
Grant, award, or other acquisition
-
903 Added 50.0%
903 Common Stock, par valu...
ECC

Erin Catherine Carter

Director
Rutherford, NJ

Track Institutional and Insider Activities on GCTK

Follow GlucoTrack, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GCTK shares.

Notify only if

Insider Trading

Get notified when an Gluco Track, Inc. insider buys or sells GCTK shares.

Notify only if

News

Receive news related to GlucoTrack, Inc.

Track Activities on GCTK